Glucose metabolism abnormalities, particularly diabetes, enhance liver fibrosis risk through oxidative stress pathway activation and chronic inflammatory response promotion, while disrupting hepatic gluconeogenesis and insulin metabolism (37). This evidence concerns the gene INS and Hepatic fibrosis.